Recognizing the increasing demand for PDCI expertise and the growing needs of our clients, we are proud to announce the addition of new staff in our Health Technology Assessment (HTA) and Reimbursement Strategy Teams.
Background
Our vision at PDCI is to be the most trusted and valued pricing and reimbursement strategic partner. ... Read More
23
Oct2018
01
Oct2018
Did you or your organization submit written comments to the recent national pharmacare consultation? If so, PDCI has volunteered to accumulate & share submissions from all stakeholders on a centrally located webpage available here.
If you would like your voice added to this important policy discussion, please send ... Read More
28
Aug2018
***Participation Requested***
Sharing Responses to the National Pharmacare Public Consultation
Announced in the 2018 federal budget and chaired by former Ontario Health Minister Eric Hoskins, the Advisory Council on the Implementation of National Pharmacare is currently engaging in a national dialogue on how the federal government could implement ... Read More
27
Aug2018
PMPRB published its 2017 annual report this week, recalling an eventful year (complete with proposed amendments to its overarching regulations, poised to fundamentally change its future mandate & operations) and looking forward in 2018 to working constructively with stakeholders to finalize its Guidelines modernization initiative, underway since 2016.
PMPRB 2017 Annual ... Read More
30
Jul2018
PDCI is extremely pleased to announce the promotion of Courtney Abunassar to the position of Associate Director, Market Access and Policy. This promotion is effective immediately.
Courtney joined PDCI in September 2011 as a Junior Pricing and Reimbursement Associate. Since that time Courtney has continued to demonstrate highly strategic approaches to the ... Read More
03
Jul2018
Last week, CADTH shared its new Procedure and Submission Guidelines for the CADTH Common Drug Review document which combines the previously separate procedure and submission guidelines into a single document. Manufacturers are encouraged to follow the new guidelines immediately, however new submission requirements will be only be enforced for ... Read More
31
May2018
2019 CDEC Meeting Schedule Released
A new schedule format includes submission deadlines and guidance on when manufacturers can expect embargoed and final recommendations.
Updated Advance Notification Form (effective immediately)
New form includes an acknowledgement that information provided in the form may be shared with federal, provincial and territorial ... Read More
22
May2018
PDCI Market Access is delighted to participate in the 4th Annual Canadian Institute’s Pharma Symposium. The Pharma Symposium brings together leading stakeholders from pharmaceutical manufacturers, public/private payers, agencies, regulatory bodies and patient groups to analyze the key issues facing the industry in today’s complex environment. Participants will gain insights as ... Read More
11
May2018
PMPRB has released its May 2018 NEWSletter which includes anticipated updates on PMPRB’s timelines for its Guidelines modernization initiative:
June 2018:
PMPRB to release more specific guidance on how the PMPRB foresees operationalizing regulatory changes
PMPRB to form a multi-stakeholder Working Group to gather input on key technical aspects of ... Read More
30
Apr2018
On April 27, 2018, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers advising that their submission guide document, submission checklists and various forms and letter templates have been updated effective immediately.
For more information, please consult the following link or the ... Read More